Cancer is a very dangerous and widely spread disease worldwide. Different forms of cancer exist with the difference in the spread of each type. Women tend to receive breast cancer much more than men and it is considered as the most effective cancer in women. Breast cancer can be treated when at early stages were more extreme stages might have complications. There are two types of breast cancer invasive or non-invasive.
Being diagnosed with Ductal Carcinoma In Situ, which is a form of non-invasive breast cancer is common and can be treated. However, a recent study conducted by a team of scientists were able to find basic factors that can predict the presence of invasive breast cancer for patients who have been diagnosed with DCIS. The study was published in the Cancer Epidemiology, Biomarkers & Prevention by lead author, Ph.D. holder Jelle Wesseling, who is a professor of breast pathology in the divisions of diagnostic oncology and molecular pathology at the Netherlands Cancer Institute and Leiden University Medical Center.
Dr. Jesse commented on the findings saying, “There is a large unmet need to distinguish harmless from potentially hazardous DCIS. We hope our work will help reduce the burden of intensive treatment that thousands of women with low-risk DCIS undergo annually. We were aware of the high frequency of biases among previous studies. Some biases are inevitable, as it can be difficult to establish fully annotated cohorts, but others are easy to prevent. Our goal was to increase awareness and help the research community avoid these biases in the future.